IHS Chemical Week

Archives :: EnviroTech :: Biotech

Displaying 361 - 372 of 791 stories.
November 22, 2011
The bio-based economy is at a critical juncture. Unfortunately for anyone that believes in its vast potential for setting the world on a sustainable, prosperous future, it is not clear...
November 22, 2011
Novozymes says later today that it will open new R&D laboratories and customer solutions facilities for biofuel enzymes at its site in Araucária, Brazil. The facility has...
November 21, 2011
Privately owned Rodenburg Biopolymers (Oosterhout, the Netherlands), a biopolymer producer, has acquired Optimum (Rotterdam), also a biopolymer producer. Financial terms were not...
November 18, 2011
The chemical industry will maintain its spending of about €10 million ($13.4 million) over 2012 for its Long-range Research Initiative (LRI), a program to promote scientific...
November 14, 2011
BioAmber estimates the addressable market for its products exceed $34 billion....
November 10, 2011
The U.S. court for the Western District of Wisconsin has ordered Danisco, a DuPont company, to pay damages to Novozymes of $18.3 million. A jury found Danisco liable for...
November 10, 2011
Protéus (Nîmes, France), a biotech firm recently has been granted a U.S. patent for protein engineering and directed evolution in the manipulation of organisms for...
November 3, 2011
One of the big talking points at CPhI Worldwide, the largest expo in the world for pharmaceutical ingredients, which ran last week in Frankfurt, was around the concept of quality. The...
October 31, 2011
Biopharmaceutical company Repligen (Waltham, MA) says it has signed a definitive agreement to acquire Novozymes Biopharma Sweden (Lund, Sweden), a business of Novozymes (Bagsvaerd...
October 25, 2011
Several key manufacturers of active pharmaceutical ingredients (API) and pharmaceutical intermediates interviewed by CW at the CPhI show in Frankfurt today say that the market is...
October 21, 2011
This Week on CW:   As earnings season gathered steam reports were, once again, mixed. AkzoNobel reported net income down 32% year-on-year, to 217 million ($301 million), as the...
October 19, 2011
Europe needs to step up its investment in biotech R&D and establish supportive regulatory policies if it is to keep pace with the U.S. in the biotech sector, says Stephan Tanda...
Pages: « Previous  28 29 30 31 32 33 34 35 36 [37] 38 39 40 41 42 43 44 45 46 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa